MEDP
Medpace Holdings Inc
624.20$
+1.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.2% | 9.6% | 13.6% | 13.7% | 18.4% | 27.7% | 34.1% | 41.6% | 24.7% | 35.8% | 49.0% | 50.1% | |
| 4.9% | 1.5% | 3.8% | 2.8% | 2.4% | 11.5% | 20.0% | 27.8% | 2.1% | 14.8% | 31.9% | 25.2% | |
| 4.9% | 1.5% | 3.8% | 2.8% | 2.4% | 11.5% | 20.0% | 27.8% | 2.1% | 14.8% | 31.9% | 25.2% | |
| 5.9% | 6.6% | 8.1% | 8.7% | 13.8% | 13.6% | 11.6% | 11.2% | 18.7% | 18.0% | 14.1% | 20.4% | |
| 0.1% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | – | – | |
| 3.5% | 3.8% | 4.5% | 5.1% | 5.4% | 8.7% | 6.1% | 5.6% | 8.1% | – | – | – | |
| 61.1% | 67.2% | 67.5% | 69.5% | 68.3% | 57.9% | 47.6% | 39.9% | 49.0% | 40.0% | 31.5% | 33.5% | |
| 22.8% | 19.0% | 13.9% | 10.4% | 7.1% | 4.8% | 3.3% | 2.5% | 2.8% | 2.2% | 1.6% | 1.7% | |
| 63.4% | 58.0% | 37.6% | 47.0% | 39.1% | 36.5% | 42.1% | 42.6% | 71.4% | 66.3% | 60.7% | 76.8% | |
| 12.2% | 13.6% | 17.2% | 20.3% | 26.6% | 30.0% | 31.6% | 33.6% | 59.4% | 55.8% | 52.6% | 68.0% | |
| 1.9% | 2.0% | 1.3% | 1.7% | 9.0% | 9.6% | 9.7% | 9.6% | 3.7% | 17.7% | 1.1% | 1.2% | |
| 0.6% | 0.9% | 1.1% | 1.8% | 1.7% | 2.0% | 1.9% | 1.5% | 2.4% | 1.9% | 1.5% | 1.4% | |
| 44.8% | 41.5% | 15.4% | 21.6% | 8.2% | – | – | – | – | – | – | – | |
| 36.6% | 42.0% | 62.4% | 53.0% | 60.9% | 63.5% | 57.9% | 57.4% | 28.6% | 33.7% | 39.3% | 23.2% | |
| -1.3% | -2.3% | -1.0% | -12.7% | -4.3% | 6.0% | 8.3% | 14.2% | -26.6% | -13.4% | 0.4% | -23.3% | |
| 2.7% | 4.0% | 3.7% | 4.2% | 3.8% | 3.3% | 2.7% | 2.3% | 2.5% | 1.9% | 1.5% | 1.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.